PLURI INC
PLUR · NASDAQ
Updated at 2026-10-15 06:57:07
- Today's High
- $0.95
- Today’s Low
- $0.92
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.95
- Previous Close
- $0.93
- Volume
- 4.82K
- Market Cap
- $11.72M
- P/E Ratio
- --
- EPS
- $-2.45
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- MATAM ADVANCED TECHNOLOGY PARK, HAIFA, ISRAEL, 3508409
- Country
- IL
- Listing Date
- 2007-12-10
- Fiscal Year End
- June
- Shares Outstanding
- 10.79M
- CIK
- 0001158780
- Website
- pluri-biotech.com
Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy, utilizing its proprietary technology platform to develop advanced cell-based therapies for oncology and degenerative conditions. With a robust pipeline of therapeutics aimed at addressing critical unmet medical needs, Pluri actively forms strategic collaborations that bolster its research and development capabilities. Committed to revolutionizing patient care, Pluri is well-positioned to become a significant contributor in the biotechnology landscape, driving growth and delivering impactful healthcare solutions.
Financial Metrics
Revenue
2026-06-30
$335K
2026-03-31
$167K
2025-12-31
$198K
2025-09-30
$316K
Operating Expenses
2026-06-30
$5.61M
2026-03-31
$6.6M
2025-12-31
$6.46M
2025-09-30
$6.33M
Net Income
2026-06-30
-$5.88M
2026-03-31
-$6.17M
2025-12-31
-$6.54M
2025-09-30
-$5.85M
Net Profit Margin
2026-06-30
-1.75K%
2026-03-31
-3.69K%
2025-12-31
-3.3K%
2025-09-30
-1.85K%
Earnings Per Share
2026-06-30
$-0.54
2026-03-31
--
2025-12-31
--
2025-09-30
$-0.65
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.42M
2026-03-31
-$6.28M
2025-12-31
-$6.52M
2025-09-30
-$5.78M
Effective Tax Rate
2026-06-30
0.01%
2026-03-31
--
2025-12-31
0.11%
2025-09-30
0.13%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $335K | $167K | $198K | $316K |
| Operating Expenses | $5.61M | $6.6M | $6.46M | $6.33M |
| Net Income | -$5.88M | -$6.17M | -$6.54M | -$5.85M |
| Net Profit Margin | -1.75K% | -3.69K% | -3.3K% | -1.85K% |
| Earnings Per Share | $-0.54 | -- | -- | $-0.65 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.42M | -$6.28M | -$6.52M | -$5.78M |
| Effective Tax Rate | 0.01% | -- | 0.11% | 0.13% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.